🔗 Permalink

Inventor profile of:

Ling FU

City:

Beijing

Country:

China

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Ling FU

The entities that hold a legal rights for patent applications filed by inventor FU Ling:

Academy of Military Medical Science, PLA 3 Beijing, China
Institute of Biotechnology, Academy of Military Medical Science, PLA 1 Beijing 1, China
Institute of Biotechnology, Academy of Military Medical Science, PLA 1 Beijing, China
CANSINO BIOLOGICS INC. 1 Tianjin, China
Institute of Biotechnology Academy of Military Medical Sciences P.L.A. China 1 Beijing, China

Recent patent applications by FU Ling

Ling FU from Beijing, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260098992A1

Physics

OPTICAL SYSTEM AND DISPLAY APPARATUS

#2 | 2026-02-12

US20260043941A1

Physics

OPTICAL STRUCTURE AND DISPLAY DEVICE

#3 | 2025-12-04

US20250370267A1

Physics

OPTICAL SYSTEM, DISPLAY APPARATUS, GLASSES LENS, AND GLASSES

#4 | 2025-12-04

US20250370237A1

Physics

OPTICAL STRUCTURE AND DISPLAY APPARATUS

#5 | 2025-12-04

US20250370236A1

Physics

DISPLAY DEVICE AND OPTICAL SYSTEM

#6 | 2025-06-19

US20250204229A1

Electricity

DISPLAY APPARATUS AND MANUFACTURING METHOD THEREOF

#7 | 2025-03-27

US20250102854A1

Physics

OPTICAL SYSTEM AND DISPLAY APPARATUS

#8 | 2025-03-27

US20250102717A1

Physics

OPTICAL STRUCTURE, MANUFACTURING METHOD THEREOF AND DISPLAY DEVICE

#9 | 2025-02-13

US20250053020A1

Physics

OPTICAL SYSTEM AND DISPLAY APPARATUS

#10 | 2025-02-13

US20250052984A1

Physics

OPTICAL SYSTEM AND DISPLAY APPARATUS

#11 | 2023-01-26

US20230022109A1

Human necessities

RECOMBINANT NOVEL CORONAVIRUS VACCINE USING REPLICATION-DEFICIENT HUMAN ADENOVIRUS AS VECTOR

#12 | 2022-10-06

US20220315949A1

Chemistry; metallurgy

SINGLE PLASMID VECTOR SYSTEM FOR PACKAGING RECOMBINANT HUMAN ADENOVIRUS TYPE 4 AND APPLICATION THEREOF

#13 | 2020-12-17

US20200392188A1

Chemistry; metallurgy

Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein

#14 | 2018-09-20

US20180264100A1

Human necessities

Ebola virus disease vaccine taking human replication deficient adenovirus as vector

#15 | 2017-09-07

US20170253642A1

Chemistry; metallurgy

Platelet-derived growth factor B mutant, preparation method therefor and use thereof

InventorID:

1975979 ⎘